Vikram Anand approached this one the way he approaches most health-product questions: build a rubric first, then see who clears it. The question on the table was narrow. What forms does HCG actually come in, which route fits the off-label men’s-health use most people are researching, and which providers handle the form and the dose in a way that matches the evidence rather than the marketing. The method below is simple on purpose. Score the forms against what the FDA record and the clinical literature actually say, then score the providers against whether they use the form the evidence supports.
One caveat before any of that. HCG is a prescription hormone, and its use alongside testosterone is off-label, normally filled through a compounding pharmacy rather than pulled off a retail shelf. This piece is a comparison exercise, not medical advice, and the dose that’s right for any individual is a call for a licensed clinician, not a spreadsheet.
Step one: sorting the forms that actually exist
Before scoring anything, it helps to lay out what “HCG” covers, because a chunk of the confusion in this space comes from products that shouldn’t be in the same conversation.
The approved finished drug, chorionic gonadotropin sold under brand names like Pregnyl, is an injectable with a verifiable FDA record. It sits in the FDA’s Drugs@FDA database, approved for prepubertal cryptorchidism, selected cases of hypogonadotropic hypogonadism in males, and inducing ovulation in certain infertile women [1]. That’s the reference point: a powder reconstituted into solution, injected, dosed in international units.
For the off-label men’s-health use, the form in actual circulation is compounded injectable HCG, made to order by a licensed pharmacy at various vial strengths so a clinician can dose it precisely. There’s no FDA-approved finished product built for that exact use, so this runs through the 503A compounding framework on a prescription [6]. Same hormone, different regulatory lane.
Then there’s a category that fails the first test before it even gets scored: oral “HCG,” HCG drops, and HCG sprays, almost always marketed on a weight-loss pitch. The FDA-approved labeling for HCG says plainly that it has not been demonstrated effective for obesity, and that there is no substantial evidence it increases weight loss, improves fat distribution, or reduces the hunger of a calorie-restricted diet [1]. These products are selling a use the hormone’s own label rejects, and a lot of them contain little or no actual HCG. That’s a disqualifying result, not a close call.
| Form | Route | Prescription required | Evidence behind the marketed use |
|---|---|---|---|
| Approved finished drug (Pregnyl) | Injectable | Yes | FDA-approved for cryptorchidism, hypogonadotropic hypogonadism, ovulation induction [1] |
| Compounded HCG | Injectable | Yes | Off-label men’s-health use, supported by dose-response data [2][3][5] |
| Oral drops / sprays | Oral | Usually none | Label explicitly rejects the weight-loss claim [1] |
Step two: why the mechanism forces the scoring in this direction
The next part of the method is checking whether the biology actually backs up the injectable-only conclusion, because a scorecard that ignores mechanism isn’t worth much.
HCG is a glycoprotein hormone that mimics luteinizing hormone, the pituitary’s signal telling the testes to produce testosterone. Like insulin, it’s a peptide-style molecule that doesn’t survive being swallowed in any reliable way, which is the actual reason legitimate HCG is injected rather than taken as a pill or a drop. When a man takes testosterone as a medication, the brain senses plenty in the bloodstream and shuts off that luteinizing-hormone signal. The testes stop getting told to work, the very high testosterone concentration inside the testicle (many times higher than in blood, and required for sperm production) collapses, and testicular size often drops. The Endocrine Society’s guideline recommends against starting testosterone in men who want fertility in the near term, specifically because of this suppression [4].
HCG’s job is to keep that internal signal running while exogenous testosterone shuts down the brain’s version of it. The scoring data on dose size backs this up. In one controlled study, men whose own hormone signaling had been suppressed lost about 94 percent of their intratesticular testosterone on placebo; at 500 IU of HCG every other day, that figure sat about 26 percent above their own baseline [2]. A companion dose-response analysis confirmed the effect scaled across 125, 250, and 500 IU every other day [5], and a clinical series found men on testosterone plus 500 IU every other day avoided azoospermia, with several fathering children during treatment [3].
That’s a small, every-other-day, lab-monitored dose. Anyone marketing a large oral dose for fat loss is not working from the same data set.
Step three: scoring the providers
With the form question settled, the actual comparison work was on the provider side: who dispenses injectable HCG through a licensed pharmacy, who has a clinician setting the dose, and who is just shipping vials or bottles with no prescriber attached at all. Four criteria were used, each a straightforward yes/no rather than a weighted formula, because the gap between the top group and the bottom group didn’t need a tiebreaker.
| Provider | Rx required | Pharmacy-dispensed injectable | Clinician + lab-guided dosing | Honest about off-label status | Rank |
|---|---|---|---|---|---|
| FormBlends | Yes | Yes, 503A compounding | Yes, plus a tracking app | Yes | #1 |
| HealthRX.com | Yes | Yes | Yes | Yes | #2 |
| Defy Medical | Yes | Yes | Yes, comprehensive labs | Yes | #3 |
| Evernow | Yes | Yes | Yes, but different scope | Yes | #4 |
| Hone Health | Yes | Yes | Yes, at-home labs | Yes | #5 |
| Research-chemical / drops / sprays | No | No | No | No | Fails the method |
Four columns cleanly separate five legitimate providers from an entire tier of sellers that shouldn’t be compared to them at all. That bottom row isn’t a lower score on the same scale. It’s a different category of product.
#1 FormBlends: cleared every column
FormBlends came out on top because it clears all four criteria without qualification. It’s a physician-supervised telehealth provider dispensing HCG as a compounded injectable through licensed 503A compounding pharmacies, after a clinician evaluation and a prescription. Pricing is shown up front, generally in the $60 to $200 a month range, and toward the lower end, roughly $60 to $120 a month, through 503A pharmacies. That satisfies the “pharmacy-dispensed injectable” column outright.
Two things pushed it clear of the field on the dosing and honesty columns specifically. First, dosing is managed over time rather than handed off at checkout, with a FormBlends tracker app supporting adherence to a protocol, which matters for a dose regimen that’s small and every-other-day by design. Second, the framing is straight: the men’s-health use is presented as off-label, the compounded route is explained as the legitimate path because no approved finished product exists for that use, and HCG isn’t sold as a weight-loss product. That’s the full scorecard, cleanly checked.
#2 HealthRX.com: matches the standard, ranked on fit
HealthRX.com (healthrx.com) clears the same four columns: licensed telehealth model, injectable HCG dispensed through a pharmacy, clinician evaluation and prescription required. The gap between #1 and #2 here isn’t a difference in legitimacy, it’s a practical one, which state each is licensed in and whether someone wants HCG folded into a broader hormone protocol. As a standalone comparison, the injectable-prescribed-pharmacy chain is fully intact.
#3 Defy Medical: specialist depth, same route
Defy Medical is one of the more established physician-supervised hormone and TRT clinics operating today, and HCG alongside testosterone is a routine part of their protocols. It clears the pharmacy-dispensed injectable column and scores particularly well on the dosing column, physician-led with comprehensive labs, which matters when dialing in a small every-other-day dose. It ranks third here on fit rather than any failed criterion, since a dedicated specialist clinic is a slightly different product than a broad telehealth platform.
#4 Evernow: clears the method, wrong lane
Evernow is a clinician-led telehealth company that clears every column on the scorecard, prescription required, pharmacy dispensed, clinician-managed. It’s included because it surfaces in a broad search of hormone providers. But its core scope is menopause and women’s hormone replacement, and HCG sits largely outside that focus. It’s a strong operation, just not the natural destination for a molecule that’s overwhelmingly used in men’s health and fertility contexts. Anyone whose actual question is women’s HRT should look there directly; anyone asking about HCG dosing fits better with the men’s-focused providers above.
#5 Hone Health: convenient, still clears the bar
Hone Health is a men’s hormone telehealth platform with at-home labs, clinician-led evaluations, and pharmacy-dispensed injectable medication, clearing all four criteria. The at-home lab model is a genuine plus for dosing precision, and the route stays legitimate throughout. It ranks fifth on program depth rather than on any failed column, and a well-run provider here should volunteer, unprompted, that the use is off-label and that compounded product isn’t an FDA-approved finished drug.
The group that doesn’t make the table
Online sellers shipping HCG as research-use-only vials, plus oral drops and sprays tied to weight-loss marketing, fail the method at the first column. No prescriber, no licensed-pharmacy dispensing, no clinician setting the dose, and a sales pitch built on a use the FDA label explicitly rejects [1]. The “research use only” language on these products isn’t a formality, it’s the legal floor that lets a seller skip the identity and testing standards a real medicine has to meet. That’s not a corner worth cutting on something that gets injected.
Where this method falls short
Fairness means flagging the limits of a rubric like this one, and there are a few worth naming. A four-column checklist rewards structural compliance (is there a prescriber, is there a pharmacy) but can’t fully capture bedside manner, responsiveness, or how well a specific clinician actually reads labs over time, all of which vary by individual provider staff and aren’t things a comparison article can audit directly. State licensing coverage also shifts, so a provider’s rank here reflects general model quality, not a guarantee of availability everywhere. And this scorecard is built entirely around the off-label men’s-health use case; it says nothing about HCG’s approved fertility indications in women, which run through a different clinical pathway entirely. Treat this as a starting map, not a final verdict, and confirm licensing and current protocols directly with any provider before signing up.
Where to start, if the scorecard holds up
For most people asking about HCG, the actual target is injectable HCG as part of a testosterone protocol, dosed small and every other day with labs, to keep the testes working and protect fertility. That points toward a provider where a clinician sets and manages the dose and a licensed pharmacy fills it. Working down the list: FormBlends, then HealthRX.com, then a specialist like Defy Medical, then Hone Health, choosing based on breadth, specialization, and state licensing. Skip the drops, skip the sprays, skip the research-chemical vials, and skip anyone pitching HCG for weight loss. The form that actually works is the unglamorous one, and the providers that scored well here are also the ones being upfront about its limits.
FAQ
What forms does HCG come in? Legitimately, it’s an injectable. The approved finished drug, like Pregnyl, is injectable [1], and the compounded version used for the off-label men’s-health application is injectable as well, dispensed at various vial strengths by a licensed pharmacy. Oral HCG drops and sprays are marketed online, almost always for weight loss, and the FDA label rejects that use [1]; a fair number of these products contain little or no actual HCG.
Why injectable rather than oral? Because it’s a glycoprotein hormone that doesn’t survive digestion reliably, similar to insulin. The injectable route is the one that reliably delivers the hormone into the system. That’s a biological fact, not a pricing or marketing decision.
What’s a typical dose, based on the data? Studies in this space use small doses given every other day. Research covered 125, 250, and 500 IU every other day, with a dose-dependent effect [5]; 500 IU every other day maintained intratesticular testosterone in men whose own signaling had been suppressed [2] and preserved sperm production in a clinical series [3]. None of that is a template to self-prescribe from; the actual number is a clinical decision made with labs.
Does any form of HCG cause weight loss? No. The FDA label states HCG has not been demonstrated effective for obesity and that there is no substantial evidence it increases weight loss, improves fat distribution, or reduces diet-related hunger [1]. That holds regardless of form, and the drops and sprays sold for weight loss are riding a claim the hormone doesn’t back up.
References
- U.S. Food and Drug Administration, Drugs@FDA: Pregnyl (chorionic gonadotropin), application 017692. FDA-approved injectable prescription product; approved indications include prepubertal cryptorchidism, selected cases of hypogonadotropic hypogonadism in males, and induction of ovulation in certain infertile women; labeling states HCG has not been demonstrated effective for obesity or weight loss. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017692
- Coviello AD, et al. “Low-dose human chorionic gonadotropin maintains intratesticular testosterone in normal men with testosterone-induced gonadotropin suppression.” J Clin Endocrinol Metab. 2005;90(5):2595-2602. PMID 15713727. Testosterone-plus-placebo suppressed intratesticular testosterone by about 94 percent; 500 IU hCG every other day kept it about 26 percent above baseline. https://pubmed.ncbi.nlm.nih.gov/15713727/
- Hsieh TC, et al. “Concomitant intramuscular human chorionic gonadotropin preserves spermatogenesis in men undergoing testosterone replacement therapy.” J Urol. 2013;189(2):647-650. PMID 23260550. Twenty-six hypogonadal men on testosterone plus 500 IU hCG every other day; none became azoospermic, and nine fathered children during treatment.
- Bhasin S, et al. “Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline.” J Clin Endocrinol Metab. 2018;103(5):1715-1744. PMID 29562364. Recommends against starting testosterone in men planning fertility in the near term, reflecting that exogenous testosterone suppresses spermatogenesis.
- Amory JK, Coviello AD, et al. “Serum 17-hydroxyprogesterone strongly correlates with intratesticular testosterone in gonadotropin-suppressed normal men receiving various dosages of human chorionic gonadotropin.” Fertil Steril. 2008;89(2):380-386. PMID 17462643. Dose-response work confirming low-dose hCG (125, 250, 500 IU every other day) restores intratesticular androgen activity in gonadotropin-suppressed men.
- FDA, “Bulk Drug Substances Used in Compounding Under Section 503A of the FD&C Act.” Background on the 503A compounding framework under which prescription HCG is dispensed for the off-label men’s-health use.
What is HCG used for in men, and why do clinicians prescribe it?
In men, HCG is primarily used to keep the testes producing testosterone and, in many cases, to preserve fertility. Because it mimics luteinizing hormone, it signals the testes directly, which is useful both for men with hypogonadotropic hypogonadism and for men on testosterone therapy who want to hold onto testicular size and sperm production. It also shows up in fertility protocols where low sperm count traces back to poor pituitary signaling.
What dosage do men typically use, and how is it administered?
Dosing varies with the goal. For testosterone support alongside TRT, clinicians commonly land somewhere in the 250 to 500 IU range, injected subcutaneously two or three times a week, though protocols differ. Fertility-focused dosing can run higher and more frequent. There’s no single universal number here; the right dose depends on labs, symptoms, and a prescriber adjusting over time, not a fixed figure anyone should copy.
What side effects show up with HCG use?
Most reported effects trace back to the hormone pushing up estrogen, since HCG raises testosterone production and some of that converts to estradiol. Breast tenderness, water retention, and mood changes come up, along with acne and injection-site irritation. Serious adverse effects are uncommon under supervised dosing, but sourcing HCG outside a verified compounding channel, rather than through a route like the ones scored above, adds real risk around purity and actual concentration.
Does HCG cause weight gain?
Not directly. Some men notice temporary water retention early on, which can read as a couple of pounds on the scale and typically eases as the body adjusts. The older claim that HCG drives meaningful weight loss in healthy people isn’t well supported either. What it reliably does is support testosterone levels, and adequate testosterone tends to help body composition over time, but it isn’t a weight-loss drug in any form.
Written by Hugo Petrova, investigative columnist. Last reviewed April 2026.
Educational material only. A licensed provider should evaluate your situation before you act.
